Waldenstrom’s Macroglobulinemia Foundation of Canada
2006 Financial Statements
| ASSETS | ||
|---|---|---|
| Current assets: | ||
| Cash in bank | $50,433.08 | |
| $50,433.08 | ||
| LIABILITIES | ||
| Current liabilities: | 0.00 | |
| EQUITY | ||
| Retained earnings: | 50,433.08 | |
| $50,433.08 | ||
Approved on behalf of the Board:
signed
A. Hinchcliffe . . . . . . . . Director and President
R. J. Anderson . . . . . . . . Director and Treasurer
| Revenues: | ||||||
| Receipted donations received during the year: | ||||||
| Membership Fees | $15,700.00 | |||||
| Special “in Memory of” Donations | 4,925.00 | |||||
| Research Donations | 15,455.25 | |||||
| Unclassified Donations | 275.00 | |||||
| 36,355.25 | ||||||
| Other donations (received via the United Way, etc.) | 3,542.32 | |||||
| Total revenues | 39,897.57 | |||||
| Expenses: | ||||||
| Research contribution (to Alberta Cancer Board) (see object “b” in Note 5) |
$25,000.00 | |||||
| Payment to International Waldenstrom’s Macroglobulinemia Foundation (IWMF) for member services (part of public education and dissemination of information to persons suffering from Waldenstrom’s Macroglobulinemia (see object “a” in Note 5) |
13,589.96 | |||||
| Stationery and office supplies | 1,030.07 | |||||
| Postage and delivery costs | 347.62 | |||||
| Website costs | 243.96 | |||||
| Bank and credit card service charges | 1,044.65 | |||||
| Total expenes | 41,256.26 | |||||
| Net excess/-deficiency of revenues over expenses for the year | -$1,358.69 | |||||
| Balance, beginning of year | $ $51,791.77 | |
| Net excess/-deficiency of revenues over expenses for the year (per statement) |
-1,358.69 | |
| Balance, end of year | $50,433.08 | |
Waldenstrom’s Macroglobulinemia Foundation of Canada
Notes to the Financial Statements
December 31, 2006
- ACCOUNTING POLICIES
- Donations are recorded as revenue when received. Expenses are recorded on an accrual basis as incurred.
- INCORPORATION
- The Foundation was incorporated as a corporation without share capital under the Laws of Ontario on October 5, 2001. It received notification of registration as a charity under the provisions of the Income Tax Act effective December 27, 2002. It commenced operations in 2003.
- COMMENCEMENT OF CHARITABLE ACTIVITIES
- During 2003 the Foundation collected charitable donations in support of its activities. During 2004 the Foundation commenced charitable activities with respect to object “a” of the Foundation (see Note 5 below). During 2005 the Foundation commenced charitable activities with respect to object “b”. Such charitable activities and collection of donations continued in 2006.
- STATUS
- The Foundation has been designated as a charitable organization for purposes of the Income Tax Act (149(I)(f)).
- OBJECTS
- The objects of the Foundation are:
- To receive and maintain a fund or funds and to apply all or part of the principal and income therefrom, from time to time, for charitable purposes, and in particular for the following charitable purposes:
- to undertake public education, family support services, dissemination and publication of information about Waldenstrom’s Macroglobulinemia disease, and to coordinate medical care and social services for persons suffering from Waldenstrom’s Macroglobulinemia
- To promote and provide funds for research in the cause, control and cure of Waldenstrom’s Macroglobulinemia
- To receive and maintain a fund or funds and to apply all or part of the principal and income therefrom, from time to time, for charitable purposes, and in particular for the following charitable purposes:
- The objects of the Foundation are:
- DIRECTORS AND OFFICERS
- The officers of the Foundation are:
- Arlene Hinchcliffe – President
- Rodney J. Anderson – Treasurer
- Olga Anderson – Secretary
- The directors of the Foundation are:
- Arlene Hinchcliffe
- B. James Bunton
- Bertram T. Visheau
- Rodney J. Anderson
- Olga Anderson
- The officers of the Foundation are:
